Autologous bone marrow derived stem cell (Celvive)

N/A

Report date: 2023/02/17 21:06:04

Base Information

Drug NameAutologous bone marrow derived stem cell (Celvive)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEgypt

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCelvive

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCairo University

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A